Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Novel Alzheimer's disease-associated variants and genetic interactions identified from UK biobank whole-exome sequencing data using IBI-DT.

Scientific reports·2026

Same author

5'-end uridine-derived base modification for siRNAs potency reinforcement.

Cell & bioscience·2026

Same author

Manganese Pyrophosphate Mineralized DNA Nanovaccine Elicits Potent Humoral and Cellular Immunity.

Angewandte Chemie (International ed. in English)·2026

Same author

Dynamic regulation-based stabilizing mutations are highly effective for designing RSV pre-fusion F mRNA vaccines.

Biochemical and biophysical research communications·2026

Same author

Engineering a safe and potent LNP-mRNA delivery system by leveraging the dual activities of α-tocopherol.

International journal of pharmaceutics: X·2026

Same author

Ubiquitin-dependent degradation of MBD3 by TRIM59 promotes lung adenocarcinoma.

Acta biochimica et biophysica Sinica·2026

Same journal

DRIVE v3: Command Line Application for Identity-by-Descent Haplotype Clustering in Large Biobank Scale Data.

Genetic epidemiology·2026

Same journal

Deep Unsupervised Domain Adaptation for Translating Cancer Dependency Maps From Cell Lines to Breast Cancer Tumor Genomics.

Genetic epidemiology·2026

Same journal

Polygenic Risk Scores for Incident Dementia in the Multi-Ethnic Study of Atherosclerosis.

Genetic epidemiology·2026

Same journal

Outcome and Exposure Polygenic Risk Scores Can Help Reduce Information Bias and Selection Bias in Regression Estimates From Biobank Data.

Genetic epidemiology·2026

Same journal

Comment on: A Novel Mendelian Randomization Method With Binary Risk Factor and Outcome.

Genetic epidemiology·2026

Same journal

Shared and Distinct Genetic Factors Underlying Bile Acid Regulation and Intrahepatic Cholestasis of Pregnancy.

Genetic epidemiology·2026

See all related articles

Search research articles

Home
Individualized Bayesian Inference Identifies Novel Genetic Variants For Parkinson's Disease.

Home
Individualized Bayesian Inference Identifies Novel Genetic Variants For Parkinson's Disease.

Related Experiment Video

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Individualized Bayesian Inference Identifies Novel Genetic Variants for Parkinson's Disease.

Jin Ren¹, Yasaman J Soofi², Md Asad Rahman^1,2

¹Department of Epidemiology, University of Florida, Gainesville, Florida, USA.

Genetic Epidemiology

|June 27, 2026

View abstract on PubMed

Summary

This summary is machine-generated.

Individualized Bayesian Inference (IBI) enhances Parkinson's disease (PD) genetic research by identifying low-frequency variants missed by genome-wide association studies (GWAS). This method offers a complementary approach for prioritizing PD candidate genes and variants.

More Related Videos

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Identification and Classification of Position-specific GABA_A Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes

Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes

Published on: July 18, 2008

Related Experiment Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Identification and Classification of Position-specific GABA_A Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes

Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes

Published on: July 18, 2008

Area of Science:

Genetics
Neuroscience
Computational Biology

Background:

Parkinson's disease (PD) has a significant genetic basis.
Genome-wide association studies (GWAS) identify common genetic variants but may miss rare ones.
Individualized Bayesian Inference (IBI) offers a novel approach for variant prioritization.

Purpose of the Study:

To evaluate the effectiveness of IBI in identifying and prioritizing genetic markers for PD.
To compare IBI's performance against traditional GWAS in PD genetics.
To explore IBI's ability to detect variants with lower minor allele frequencies.

Main Methods:

Analysis of genetic data from 8840 individuals (8585 PD cases, 255 controls) from the Fox Insight study.
Application of Individualized Bayesian Inference (IBI) for variant prioritization.

Comparison of IBI-prioritized single nucleotide polymorphisms (SNPs) with GWAS-identified SNPs using Artificial Neural Network (ANN) models.

Main Results:

IBI successfully prioritized genetic variants not detected or ranked lower by GWAS.
IBI identified variants within or near known PD-associated genes.
IBI-selected SNPs demonstrated superior predictive performance (AUC=0.79) compared to GWAS SNPs (AUC=0.72) in ANN models.
IBI highlighted low minor allele frequency variants missed by GWAS.

Conclusions:

IBI serves as a valuable complementary tool to GWAS for PD genetic research.
IBI enhances the identification and prioritization of candidate PD-related variants and genes.
This approach can uncover genetic factors with individual-specific relevance or lower frequencies.